Demographics of 100 patients with meibomian gland dysfunction who were treated with either oral azithromycin or oral doxycycline
| Azithromycin (50) | Doxycycline (50) | p Value | |
|---|---|---|---|
| Male/female | 24/26 | 26/24 | 0.8 |
| Mean (SD) of age (years) | 42 (16.3) | 38.5 (14.6) | 0.2 |
| Mean (SD) duration of disease (weeks) | 14.2 (11.9) | 10.3 (7.3) | 0.057 |
| Chief complaint | |||
| Itching | 10 (20%) | 8 (16%) | 0.3 |
| Foreign body sensation | 13 (26%) | 11 (22%) | |
| Dryness | 17 (34%) | 13 (26%) | |
| Burning | 9 (18%) | 12 (24%) | |
| Lid swelling | 1 (2%) | 6 (12%) | |
| Systemic diseases | |||
| None | 26 (52%) | 4 (8%) | 0.6 |
| Diabetes mellitus | 8 (16%) | 2 (4%) | |
| Chronic anaemia | 2 (4%) | 3 (6%) | |
| Ischaemic heart disease | 5 (10%) | 2 (4%) | |
| Asthma | 2 (4%) | 12 (24%) | |
| Gastrointestinal | 7 (14%) | 4 (8%) | |